Today: 1 May 2026

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma shares fell 4.2% to around $197.25 in late trading December 9 after a Q3 earnings miss and a three-month FDA review delay for its key dwarfism drug. Volume was about 76% below average. The company posted Q3 revenue of €213.6 million but reported a net loss of €61 million, mainly from finance expenses. Despite the pullback, ASND remains near its 52-week high and up year-on-year.
9 December 2025
··
BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies shares jumped 8.4% to $38.85 intraday on December 9, 2025, after confirming control of 3.86 million ETH—over 3.2% of all Ethereum—and a $13.2 billion crypto and cash reserve. The company’s market cap stands at $14.8 billion with a trailing P/E of about 2.7. The stock traded between $34.66 and $39.25 during the session. Volume averaged 45 million shares over 30 days.
9 December 2025
····
KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (NYSE: BEKE) shares fell about 4.8% Tuesday, opening near $16.35 after closing at $17.08, with over 1 million shares traded. The drop came despite ongoing share buybacks and Q3 revenue rising 2.1% year-on-year to RMB 23.1 billion. Net income fell to RMB 747 million from RMB 1.17 billion a year earlier. BEKE underperformed even as international ETF VXUS saw strong inflows.
9 December 2025
····
Circle (CRCL) Stock Today: Abu Dhabi License, Bybit Deal and 2026 Forecast After a Wild First Year on Wall Street

Circle (CRCL) Stock Today: Abu Dhabi License, Bybit Deal and 2026 Forecast After a Wild First Year on Wall Street

Circle (CRCL) shares rose about 5% to $88–89 on December 9, 2025, after securing an Abu Dhabi license and announcing a partnership with Bybit. The stock remains far below its 52-week high of $299. Q3 revenue jumped 66% year-on-year, but over 90% still comes from USDC reserve interest. Heavy insider selling contrasts with major institutional buying, including an 8.5 million-share stake by Marshall Wace.
9 December 2025
·
O’Reilly Automotive (ORLY) Stock Outlook: Institutional Buying, Q3 Beat and 2026 Growth Drivers as of December 9, 2025

O’Reilly Automotive (ORLY) Stock Outlook: Institutional Buying, Q3 Beat and 2026 Growth Drivers as of December 9, 2025

O’Reilly Automotive shares fell 3.9% to $94.31 on December 9, 2025, with trading volume near 5 million, following a recent stock split. Multiple large institutional investors disclosed sharply increased stakes. Third-quarter results showed 5.6% same-store sales growth and a 12% rise in diluted EPS to $0.85, beating estimates. Management raised the lower end of 2025 revenue guidance.
9 December 2025
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics shares traded at $17–18 on December 9, 2025, near the low end of their 52-week range of $15.55 to $36.91. The company’s lung cancer drug ivonescimab recently outperformed Keytruda in a limited trial, drawing attention but also regulatory questions. Summit granted inducement stock options to new hires on December 5. The company’s market cap stands near $13–14 billion.
9 December 2025
·
Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group shares traded near $169 on December 9, 2025, down from a record $213.80 hit a week earlier after strong earnings. The company reported Q2 fiscal 2026 revenue of $268 million, far above estimates, and net income of $82.6 million versus a loss last year. Management raised Q3 guidance to $335–$345 million in revenue, citing demand from AI data centers.
9 December 2025
···
Warner Bros. Discovery, Inc. – Series A (WBD) Stock on December 9, 2025: Netflix vs. Paramount Skydance Takeover War, Analyst Downgrades and Fresh Price Targets

Warner Bros. Discovery, Inc. – Series A (WBD) Stock on December 9, 2025: Netflix vs. Paramount Skydance Takeover War, Analyst Downgrades and Fresh Price Targets

Warner Bros. Discovery shares closed at $27.70 on December 9, 2025, near takeover levels as Netflix and Paramount Skydance compete for control. Netflix has offered $82.7 billion for Warner’s studios and streaming assets, with shareholders set to receive $23.25 in cash and $4.50 in Netflix stock per share. Trading volume topped 22 million shares. Analysts have grown cautious as regulators review the bids.
9 December 2025
··
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals shares traded at $26–27 on December 9, up over 800% from their 52-week low but 12% below the recent high. The stock surged after Roche’s positive Phase 3 results for a similar breast cancer drug, triggering analyst upgrades and price target hikes. Market capitalization now stands near $2–2.2 billion. Analyst 12-month targets range from $20 to $55, with most rating the stock a strong buy.
9 December 2025
··
Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises reported Q1 net sales of $8.17–8.2 billion, up 5.1% year-on-year, and adjusted diluted EPS of $2.84, up 15.9%. Shares fell sharply despite raised full-year guidance, as investors weighed valuations and growth forecasts. Residential revenue slipped 1%, while non-residential revenue jumped 12% on strong commercial demand. The company now targets 5% net sales growth for 2025.
9 December 2025
···
Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging shares fell to a new 52-week low near $14 on December 9, 2025, after the company cut its full-year earnings outlook and announced cost and production optimization measures. Trading volume topped 10 million shares. The company also confirmed a CEO transition for early 2026. Net sales guidance remains at $8.4–$8.6 billion.
9 December 2025
··
SLM Stock Plunges Over 16% After Investor Day: New EPS Targets, Analyst Downgrades and 2026–2028 Outlook for Sallie Mae (SLM)

SLM Stock Plunges Over 16% After Investor Day: New EPS Targets, Analyst Downgrades and 2026–2028 Outlook for Sallie Mae (SLM)

SLM Corporation shares plunged 16–17% to about $25.85 on December 9 after its Investor Forum revealed sharply lower earnings guidance for 2026 and 2027. Management projected FY26 EPS of $2.63, about 23% below prior consensus, and signaled higher operating expenses tied to a strategic shift. Trading volume was several times normal. The stock now trades just above its 52-week low.
9 December 2025
·
Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems shares traded at $141.72 on December 9, 2025, after a volatile year that included a 21% surge two weeks prior following an analyst upgrade and positive reimbursement news. Q3 revenue rose 10% to $224.5 million, with net income at $9.9 million and adjusted EPS of $0.38, beating estimates. The company also launched its new Inspire 5 system.
9 December 2025
·
Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands shares traded between $75 and $76 on December 9, about 19% below their January high, after falling 3–4% intraday amid weak consumer data. Wells Fargo raised its price target to $100 and reiterated an “overweight” rating. Marshall Wace trimmed its stake following recent gains. Kontoor’s Q3 revenue rose 27% to $853 million, with EPS of $1.44 beating forecasts.
9 December 2025
··
1 … 1,283 1,284 1,285 1,286 1,287 … 1,887

Stock Market Today

  • Lloyds Banking Group Issues 20.5 Million New Shares on London Stock Exchange
    May 1, 2026, 9:43 AM EDT. Lloyds Banking Group plc has issued and admitted to trading 20,518,682 new ordinary shares, each with a nominal value of 10p, on the London Stock Exchange's Main Market between March 4 and April 30, 2026. These shares are part of the Company's block listed shares intended to satisfy share plan awards, increasing the total shares admitted to trading to approximately 58.5 billion. Fully fungible with existing shares, this issuance follows previous block admissions under UK Listing Rules. The move reflects ongoing equity compensation activities within the Group and impacts the shareholder base by expanding the number of outstanding shares.

Latest article

Reddit Stock Jumps as AI Ad Tools Put Wall Street on Notice

Reddit Stock Jumps as AI Ad Tools Put Wall Street on Notice

1 May 2026
Reddit shares rose 16% in premarket trading after the company forecast second-quarter revenue of $715 million to $725 million, topping Wall Street estimates. First-quarter revenue jumped 69% to $663 million, with ad revenue up 74% to $625 million. Daily active unique visitors reached 126.8 million, up 17% from a year ago. Reddit reported net income of $204 million, or $1.01 per diluted share.
Apple Inc Stock Rises as $100 Billion Buyback and iPhone 17 Demand Reset CEO Handoff

Apple Inc Stock Rises as $100 Billion Buyback and iPhone 17 Demand Reset CEO Handoff

1 May 2026
Apple forecast stronger-than-expected June-quarter sales and approved a new $100 billion stock buyback, sending shares up 0.3% premarket to $271.35. Fiscal Q2 revenue rose 17% to $111.2 billion, with iPhone sales at $56.99 billion, slightly below estimates due to chip supply limits. Apple raised its dividend 4% and dropped its net cash neutral target. Cook warned higher memory costs will impact results from June.
Atmos Energy Stock Faces May 6 Earnings Test as Wall Street Eyes Rate-Driven Growth

Atmos Energy Stock Faces May 6 Earnings Test as Wall Street Eyes Rate-Driven Growth

1 May 2026
Atmos Energy will report fiscal Q2 results after markets close May 6, with a call set for May 7. Zacks estimates earnings at $3.36 per share on $2.22 billion revenue, though MarketBeat projects lower revenue at $1.94 billion. Atmos shares closed at $189.94 on April 30, up 2.28%. The company affirmed full-year guidance of $8.15 to $8.35 per share in February.
Go toTop